Navigation Links
Vanda Pharmaceuticals Reports First Quarter 2009 Results
Date:4/29/2009

kes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

                           VANDA PHARMACEUTICALS INC.
                        (A Development Stage Enterprise)

            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

                                             Three Months Ended
                                             ------------------
                                        March 31,          March 31,
                                           2009               2008
                                           ----               ----

    Revenue                                    $-                  $-
                                            -----               -----
    Operating expenses:
      Research and development          2,333,344          11,102,665
      General and administrative        4,224,031           8,959,214
                                        ---------           ---------
         Total operating expenses       6,557,375          20,061,879
                                        ---------          ----------

    Loss from operations               (6,557,375)        (20,061,879)

    Interest income                        53,387             865,750
                                           ------             -------
         Total other income, net           53,387             865,750
                                           ------             -------

    Net loss                          $(6,503,988)       $(19,196,129)
                                      ===========        ============

    Basic and diluted net loss per
     share attributable to
     common stockholders
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
2. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
3. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
6. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
7. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
8. Onyx Pharmaceuticals Announces First Quarter 2009 Financial Results Teleconference and Webcast
9. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
10. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
11. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... An interdisciplinary team of researchers led by Northeastern ... constructing precise inter-nanotube junctions and a variety of ... is facile and easily scalable, which will allow ... nanotube networks for use in applications ranging from ... everything from cars to sports equipment. , Their ...
(Date:9/15/2014)... 2014 Zymo Research Corp., has announced the ... safe ambient temperature storage and transport of infectious ... of agents in such samples is completely inactivated ... the viral nucleic acids for subsequent analyses.  With ... in West Africa and ...
(Date:9/15/2014)... Research and Markets has announced the addition of ... by Technology, by Application - Global Forecast to 2018" ... (WES) is next-generation technology used for strategically sequencing the coding ... is the total of all exons of an organism, represents ... into proteins after translation. It is responsible for the occurrence ...
(Date:9/15/2014)... CA (PRWEB) September 15, 2014 ... term implantable silicones for the medical device and ... silicone gel for the implantable medical device market. ... unique crosslink technology delivering a silicone gel with ... The Dual Matrix technology consists of two crosslinked ...
Breaking Biology Technology:Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 2Safe storage and transport of Ebola, Mers-CoV, and other viruses: Groundbreaking viral inactivation solution capable of preserving nucleic acids 3Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2
... TRIANGLE PARK, N.C., Dec. 14, 2010 Talecris Biotherapeutics Holdings ... jury in the General Court of Justice, Superior Court Division, ... 2010 in the amount of $37 million in favor of ... Resources, Inc., in a breach of contract claim. ...
... available in Spanish . The researchers decided ... which mechanisms are used by plants when they extract water ... of mangrove swamps, for example, the plants are able to ... the osmotic pressure should make quite the opposite happen", explains ...
... Utilizing a century-old phenomenon discovered in St. Paul,s Cathedral, ... the first time, highly collimated unidirectional microlasers. The ... in Hamamatsu City, Japan, and the Institute of Theoretical ... has a wide range of new applications in photonics ...
Cached Biology Technology:Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute 2A study analyzes the movement of tree sap 2Capasso lab demonstrates highly unidirectional 'whispering gallery' microlasers 2
(Date:9/15/2014)... , , , , , ... , , , , ... eight genetically distinct disorders, each with its own set of symptoms. The finding could be a first... , ... , , , , , ... , , , , , , ...
(Date:9/15/2014)... This news release is available in German . ... as a substitute for the fossil energy carrier natural ... a sustainable energy supply. Nevertheless, a consequent market penetration ... and transnational frame conditions. Scientists of the Helmholtz Centre ... Centre (DBFZ) and other Members of the IEA Task ...
(Date:9/12/2014)... Ireland , September 12, 2014 /PRNewswire/ ... Markets ( http://www.researchandmarkets.com/research/trs4c7/global ) has announced the ... Industry Report 2014" report to their ... Lock Industry Report 2014 is a professional ... of the global fingerprint lock industry. , ...
Breaking Biology News(10 mins):Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5The biomethane market needs clear frame conditions for further growth 2The biomethane market needs clear frame conditions for further growth 3Global Fingerprint Lock Industry Report 2014 2
... planet,s tiniest inhabitants may help address two of society,s ... vast quantities of organic waste produced and where to ... Torres and Sudeep Popat, researchers at Arizona State University,s ... converting waste into useful energy. These microorganisms are ...
... more than 272,000 maternal deaths from childbirth each year, ... the Johns Hopkins Bloomberg School of Public Health. Researchers ... contraception could reduce maternal deaths an additional 30 percent. ... Lancet as part of a series of articles ...
... Models & Mechanisms, one-day symposium entitled Protein-Folding Diseases: ... Symposium will focus on how misfolded proteins contribute ... and whole-organism level, highlighting the diverse biological models ... It is becoming increasingly clear that protein misfolding ...
Cached Biology News:Waste to watts: Improving microbial fuel cells 2Waste to watts: Improving microbial fuel cells 3Waste to watts: Improving microbial fuel cells 4Contraceptive use averts 272,000 maternal deaths worldwide 2
Anti-Salmonid Ig (H), Alk Phos, (Clone IPA5F12) (mouse IgG2a)...
Rat monoclonal [HK5.3] to B7 RP1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: